OneMedNet Corp (ONMD) · Nov 6, 2026 · Earnings

OneMedNet earnings point to Q4 revenue surge, pending acceptance

Guidance issued — Q4 revenue forecast of approximately $12M-$14M

OneMedNet’s earnings update shows Q3 revenue acceleration and a dramatic Q4 forecast, but the outlook depends on customers accepting delivered data.

OneMedNet is transitioning from its decommissioned BEAM platform toward an iRWD business that sells curated, de-identified medical and clinical data to drugmakers, device companies, and AI developers. That pivot was beginning to show in 2025, when data-delivery revenue reached $1.254 million, while the company’s first-half 2026 revenue was still only $388,000.

Q3 2026Q2 2026Q3 2025
Revenue (Press release)$1.0M$0.292M~$0.177M
Q4 revenue guidance (Press release)$12M-$14M

The quarter shows real commercial conversion, not just a larger sales funnel. OneMedNet expects roughly $1 million of Q3 revenue, up 242% from the prior quarter and 465% from the year-earlier quarter. That is meaningful because the company had previously been describing customer pipeline and bookings momentum; this update says deliveries have started converting into recognized revenue at scale.

The Q4 outlook is the material change, but it is still execution-dependent. The company forecasts $12 million to $14 million of Q4 revenue—roughly 12 to 14 times the preliminary Q3 figure—pending customer acceptance of delivered data. There is no reliable published consensus to establish a formal beat, so the better benchmark is the standing story: the direction of acceleration was already telegraphed, but this magnitude would represent a sharp step-up if the data is accepted and revenue is recognized.

The evidence is encouraging, but the forecast is not yet fully validated. Q3 revenue remains preliminary and may change when the company files its 10-Q, while the Q4 range depends on customer acceptance rather than signed delivery alone. 〔0〕 The filing therefore advances the commercialization story, but it does not yet prove that the projected Q4 run rate is repeatable.

Bottom line: This is a meaningful early validation of OneMedNet’s shift from building its data platform to monetizing it. The Q4 forecast is potentially transformative relative to the company’s small historical revenue base, but customer acceptance and the upcoming 10-Q are the key confirmation points.

What to watch next

Q3 10-Q expected by November 16, 2026

Original filing on SEC EDGAR

More OneMedNet Corp news

OneMedNet earnings point to Q4 revenue surge, pending acceptance | ONMD Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.